European Medicines Agency invites feedback on the draft guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis

View source ↗

Summary

EMA invites feedback on a draft guideline outlining clinical investigation considerations for medicinal products intended to treat multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis